Overview Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors Status: Completed Trial end date: 2013-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the pharmacokinetic and safety profiles of two formulations of CO-1.01 in patients with Advanced Solid Tumors. Phase: Phase 1 Details Lead Sponsor: Clovis Oncology, Inc.